These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 8995313
1. Mechanism of E1A-induced transforming growth factor-beta (TGF-beta) resistance in mouse keratinocytes involves repression of TGF-beta type II receptor transcription. Kim DH, Chang JH, Lee KH, Lee HY, Kim SJ. J Biol Chem; 1997 Jan 03; 272(1):688-94. PubMed ID: 8995313 [Abstract] [Full Text] [Related]
2. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1. Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW. J Cell Physiol; 2003 Jan 03; 194(1):88-99. PubMed ID: 12447993 [Abstract] [Full Text] [Related]
3. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene. Im YH, Kim HT, Lee C, Poulin D, Welford S, Sorensen PH, Denny CT, Kim SJ. Cancer Res; 2000 Mar 15; 60(6):1536-40. PubMed ID: 10749119 [Abstract] [Full Text] [Related]
4. Induction of transforming growth factor beta 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins. Missero C, Filvaroff E, Dotto GP. Proc Natl Acad Sci U S A; 1991 Apr 15; 88(8):3489-93. PubMed ID: 1673033 [Abstract] [Full Text] [Related]
5. Regulation of parathyroid hormone-related protein gene expression in murine keratinocytes by E1A isoforms: a role for basal promoter and Ets-1 site. Foley J, Wysolmerski JJ, Missero C, King CS, Philbrick WM. Mol Cell Endocrinol; 1999 Oct 25; 156(1-2):13-23. PubMed ID: 10612419 [Abstract] [Full Text] [Related]
6. Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1A. Proffitt JL, Sharma E, Blair GE. Nucleic Acids Res; 1994 Nov 11; 22(22):4779-88. PubMed ID: 7984430 [Abstract] [Full Text] [Related]
7. Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells. Tarakanova VL, Wold WS. J Virol; 2003 Sep 11; 77(17):9324-36. PubMed ID: 12915548 [Abstract] [Full Text] [Related]
8. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation. Hypes MK, Pirisi L, Creek KE. Cancer Lett; 2009 Sep 18; 282(2):177-86. PubMed ID: 19344999 [Abstract] [Full Text] [Related]
9. Repression of transforming growth factor beta 1 promoter by the adenovirus oncogene E1A. Identification of a unique GC-rich sequence as a target for E1A repression. Datta PK, Bagchi S. J Biol Chem; 1994 Oct 14; 269(41):25392-9. PubMed ID: 7929236 [Abstract] [Full Text] [Related]
10. Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1. Kornuc M, Kliewer S, Garcia J, Harrich D, Li C, Gaynor R. J Virol; 1990 May 14; 64(5):2004-13. PubMed ID: 2139139 [Abstract] [Full Text] [Related]
11. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2. Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D, Freeman JW. Cancer Res; 2001 Aug 15; 61(16):6239-47. PubMed ID: 11507078 [Abstract] [Full Text] [Related]
12. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression. Park SH, Kim YS, Park BK, Hougaard S, Kim SJ. Oncogene; 2001 Mar 08; 20(10):1235-45. PubMed ID: 11313868 [Abstract] [Full Text] [Related]
13. Identification of a negative Cis-regulatory element and multiple DNA binding proteins that inhibit transcription of the transforming growth factor-beta type II receptor gene. Song SU, Oh IS, Lee B, Suh JK, Kim JH, Cha YD, Lee KH, Kim DH. Gene; 2001 Jan 10; 262(1-2):179-87. PubMed ID: 11179682 [Abstract] [Full Text] [Related]
14. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ, Kim SJ. Nat Genet; 1999 Oct 10; 23(2):222-7. PubMed ID: 10508522 [Abstract] [Full Text] [Related]
15. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression. Mi Y, Borger DR, Fernandes PR, Pirisi L, Creek KE. Virology; 2000 May 10; 270(2):408-16. PubMed ID: 10793000 [Abstract] [Full Text] [Related]
16. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells. Park SH, Birchenall-Roberts MC, Yi Y, Lee BI, Lee DK, Bertolette DC, Fu T, Ruscetti F, Kim SJ. Cell Growth Differ; 2001 Jan 10; 12(1):9-18. PubMed ID: 11205746 [Abstract] [Full Text] [Related]
17. Effect of ets-related transcription factor (ERT) on transforming growth factor (TGF)-beta type II receptor gene expression in human cancer cell lines. Lee HJ, Chang JH, Kim YS, Kim SJ, Yang HK. J Exp Clin Cancer Res; 2003 Sep 10; 22(3):477-80. PubMed ID: 14582709 [Abstract] [Full Text] [Related]
18. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7. Quan T, He T, Voorhees JJ, Fisher GJ. J Biol Chem; 2001 Jul 13; 276(28):26349-56. PubMed ID: 11320083 [Abstract] [Full Text] [Related]
19. Counteracting effects of E1a transformation on cAMP growth inhibition. Florin-Christensen M, Missero C, Florin-Christensen J, Tranque P, Ramon y Cajal S, Dotto GP. Exp Cell Res; 1993 Jul 13; 207(1):57-61. PubMed ID: 8391467 [Abstract] [Full Text] [Related]
20. Down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells is accompanied by an increase in factor binding. Ge R, Kralli A, Weinmann R, Ricciardi RP. J Virol; 1992 Dec 13; 66(12):6969-78. PubMed ID: 1433502 [Abstract] [Full Text] [Related] Page: [Next] [New Search]